Bloomberg Takeda Pharmaceutical Co agreed to pay as much as $6 billion for an experimental immune therapy from Nimbus Therapeutics, part of the Japanese drugmaker’s hunt for promising new products. Takeda will pay $4 billion upfront for the drug, which is called NDI-034858 and will be renamed TAK-279, the companies said in a statement. Cambridge, Massachusetts-based Nimbus is also ...

Bloomberg Senator Joe Manchin is pressing Treasury Secretary Janet Yellen to stand firm on North American-based manufacturing requirements for lucrative electric-vehicle tax credits under the Inflation Reduction Act, setting up a battle between the West Virginia Democrat and Korea’s Hyundai Motor Co. At stake is whether Treasury would hand out the full $7,500 per vehicle in tax credits to more ...

Bloomberg The US is poised to send Patriot air and missile defense batteries to Ukraine pending final approval from President Joe Biden, two US officials said, fulfilling a key demand from Ukrainian leaders. President Volodymyr Zelenskiy has urgently sought the system, produced by Raytheon Technologies Corp.and Lockheed Martin Corp, saying Patriots are needed to counter the relentless barrage of Russian ...